BioPharmSignal logoBioPharmSignal

Biotech News

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

iRadimed (IRMD)iRadimedEarnings

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on Friday, October 30, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Related news

IARTIntegra LifeSciences2026-10-06 12:30 EST

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

LUNGPulmonx2026-10-13 20:05 EST

Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026

CVRXCVRx2026-10-22 20:30 EST

CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026

AORTArtivion2026-10-22 20:10 EST

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results

PLSEPulse Biosciences2026-10-22 20:05 EST

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

STIMNeuronetics2026-10-21 12:30 EST

Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call

TMCITreace Medical Concepts2026-10-23 11:05 EST

Treace to Report Third Quarter 2026 Financial Results on November 6, 2026

DNLIDenali Therapeutics2026-10-22 20:01 EST

Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026

APYXApyx Medical2026-10-22 12:00 EST

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

SGHTSight Sciences2026-10-21 20:05 EST

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

View all latest news

iRadimed

MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures. Its core portfolio includes non-magnetic IV infusion pump systems and patient vital signs monitoring systems, along with related accessories, disposables, and services. This gives the...

Recent company news

IRMDiRadimed2026-10-23 12:30 EST

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

IRMDiRadimed2026-09-23 13:00 EST

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

IRMDiRadimed2026-07-31 12:15 EST

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

IRMDiRadimed2026-07-24 20:15 EST

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

IRMDiRadimed2026-05-20 12:30 EST

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Stock data

Close
87.64 USD
Market cap
1.15B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States